Document is current

Article History

Accepted: 31 July 2024

First Online: 4 September 2024

Declarations

:

: All procedures performed in this study were in line with the principles of the Declaration of Helsinki. The study was approved by the Institutional Review Board at Baylor College of Medicine.

: All participants provided their assent or consent based on their age to participate in the study.

: Ms. Kook, Ms. Rast, Ms. Clinger, Ms. Smith, Ms. Draper, Dr. Schneider, and Dr. Pinciotti have no financial disclosures to report. Dr. Cervin discloses research support from the Swedish Research Council for Health, Working Life and Welfare, the Lindhaga Foundation, Stiftelsen Clas Grochinskys Minnesfond, the Crown Princess Lovisa's Association, Region Skåne, and Skåne University Hospital’s Foundations and Donations. Dr. Murphy discloses research support from the Misophonia Research Fund/Ream Foundation, and the National Institute of Mental Health. Dr. Marijn Lijffijt currently works at Sage Therapeutics. Dr. Parnes discloses the following relationships: data and safety monitoring board for Teva Pharmaceuticals, focus group for Alexion Pharmaceuticals, consultant for GuidePoint. The institution of Dr. Parnes has received research support from NIH, PTC Therapeutics, Alexion Pharmaceuticals, and Neurocrine Biosciences. Dr. Goodman receives research funding from NIH, Biohaven, and the McNair Foundation and consulting fee from Biohaven. He also received honorarium from NView for licensing of the YBOCS scales. Dr. Storch discloses the following relationships: consultant in the last 12 months for Biohaven Pharmaceuticals and Brainsway; Book royalties from Elsevier, Springer, American Psychological Association, Wiley, Oxford, Kingsley, and Guilford; Stock valued at less than $5000 from NView for licensing of the YBOCS scales; Research support from NIH, IOCDF, Ream Foundation, and Texas Higher Education Coordinating Board. Dr. Guzick discloses research support from the Misophonia Research Fund/Ream Foundation.